Stay updated on Solanezumab vs Placebo in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.

Latest updates to the Solanezumab vs Placebo in Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check13 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.4%
- Check20 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check57 days agoChange DetectedThe page has undergone significant content removal related to the study of solanezumab for Alzheimer's Disease, including detailed inclusion and exclusion criteria for participants. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference7%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Solanezumab vs Placebo in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.